2622
A. A. El-Shehawy / Tetrahedron: Asymmetry 17 (2006) 2617–2624
(2.0 mL) under nitrogen, at room temperature, and the
reaction mixture was cooled to 0 ꢁC. To this mixture,
0.9 mL (0.9 mmol) of 1 M Et2Zn in hexane was added
dropwise. After stirring at 0 ꢁC for 30 min, the reaction
mixture was cooled to ꢀ20 ꢁC and TIPSCl (64 lL,
0.3 mmol) was added. Stirring was continued for 24 h at
that temperature and the reaction mixture then quenched
with saturated aqueous NH4Cl. The aqueous phase was
extracted with CH2Cl2 (3 · 15 mL), and the combined
organic layers dried over MgSO4. After removal of the sol-
vents, the residue was purified by flash chromatography on
silica gel (deactivated silica gel, pentane/ethyl acetate: 95:5–
30:70) to afford 4-[1-(40-methoxyphenyl)propyl]amino-3-
mercapto-6-methyl-4H-1,2,4-triazin-5-one 4e in 95% yield
(87.3 mg) as a white solid and in 88% ee. The enantiomeric
purity of 4e could be upgraded to 92% by simple crystal-
lization from hexane/ethanol (1:9). The product was ana-
lyzed by HPLC on a Chiralcel OD-H column. The yields
and enantiomeric compositions of the secondary amines
obtained with arylimines 2a–f are shown in Tables 2 and 3.
4.1.5.
4-[1-(40-Methylphenyl)propyl]amino-3-mercapto-6-
methyl-4H-1,2,4-triazin-5-one 4c. White solid, mp 182–
25
183 ꢁC; ½aꢁD ¼ ꢀ78:1 (c 1.28, CH2Cl2); HPLC conditions:
i
15% PrOH in hexane, retention times, 21.55 min (minor,
R-isomer) and 27.82 min (major, S-isomer); IR (cmꢀ1
)
3280 (NH), 1703 (C@O), 1208 (C@S); 1H NMR
(400 MHz, CDCl3): d (ppm) 0.86 (t, 3H, J = 7.6 Hz,
CH3CH2), 1.74–1.87 (m, 1H, CH2CH3), 1.97–2.13 (m,
1H, CH2CH3), 2.35 (s, 3H, Ar–CH3), 2.44 (s, 3H, CH3–
C6), 3.42 (br s, 1H, NHC), 4.06–4.16 (m, 1H, CHNH),
7.07 (d, J = 8.3 Hz, 2H, HAr), 7.18 (d, J = 8.3, 2H, HAr),
11.57 (br s, 1H, SH); 13C NMR (100 MHz, CDCl3): d
(ppm) 10.95 (CH3CH2), 16.92 (CH3–C6), 21.64 (Ar–CH3),
32.2 (CH2CH3), 54.65 (CHNH), 125.88 (Ar), 128.84 (Ar),
136.38 (Ar), 140.69 (Ar), 150.43 (C6), 166.76 (C5), 170.18
(C3); MS (EI) m/z (rel. intensity) 290 (M+, 11%), 263
(27), 246 (9.5), 218 (4), 158 (9), 146 (52), 134 (18), 130
(25), 119 (21), 105 (9) and 91 (19). Anal. Calcd for
C14H18N4OS: C, 57.91; H, 6.25; N, 19.29; S, 11.04. Found:
C, 57.87; H, 6.30; N, 19.23; S, 11.12.
4.1.6. 4-[1-(20-Methoxyphenyl)propyl]amino-3-mercapto-6-
4.1.3. 4-(1-Phenylpropyl)amino-3-mercapto-6-methyl-4H-
1,2,4-triazin-5-one 4a. White solid, mp 117–118 ꢁC;
methyl-4H-1,2,4-triazin-5-one 4d. White solid, 129–
25
131 ꢁC; ½aꢁD ¼ ꢀ94:5 (c 0.77, CHCl3); HPLC conditions:
25
½aꢁD ¼ ꢀ57:4 (c 1.03, CH2Cl2); HPLC conditions: 9%
i
15% PrOH in hexane, retention times, 10.41 min (minor,
iPrOH in hexane, retention times, 20.18 min (minor, R-iso-
mer) and 27.26 min (major, S-isomer); IR (cmꢀ1) 3277
(NH), 1707 (C@O), 1205 (C@S); 1H NMR (400 MHz,
CDCl3): d (ppm) 0.89 (t, 3H, J = 7.5 Hz, CH3CH2), 1.75–
1.88 (m, 1H, CH2CH3), 1.96–2.08 (m, 1H, CH2CH3),
2.38 (s, 3H, CH3–C6), 3.42 (m, 1H, NHN), 4.04–4.16 (m,
1H, CHNH), 7.33–7.68 (m, 5H, HAr), 12.17 (br s, 1H,
SH); 13C NMR (100 MHz, CDCl3): d (ppm) 11.63
(CH3CH2), 17.92 (CH3–C6), 31.25 (CH2CH3), 56.36
(CHNH), 128.39 (Ar), 129.33 (Ar), 130.26 (Ar), 137.30
(Ar), 149.31 (C6), 165.40 (C5), 170.11 (C3); MS (EI) m/z
(rel. intensity) 276 (M+, 6%), 249 (44), 248 (14), 232 (8),
157 (14), 146 (71), 142 (6), 134 (33), 130 (17) and 119
(23). Anal. Calcd for C13H16N4OS: C, 56.50; H, 5.84; N,
20.27; S, 11.60. Found: C, 56.51; H, 5.79; N, 20.30; S,
11.58.
R-isomer) and 18.16 min (major, S-isomer); IR (cmꢀ1
)
3285 (NH), 1795 (C@O), 1209 (C@S); 1H NMR
(400 MHz, CDCl3): d (ppm) 0.76 (t, 3H, J = 7.4 Hz,
CH3CH2), 1.74–1.89 (m, 1H, CH2CH3), 1.96–2.05 (m,
1H, CH2CH3), 2.37 (s, 3H, CH3–C6), 3.28 (br s, 1H,
NHC), 3.83 (s, 3H, OCH3), 4.38–4.52 (m, 1H, CHNH),
6.98 (d, 1H, J = 8.0 Hz, HAr), 7.09 (t, 1H, J = 7.6 Hz,
HAr), 7.35 (t, 1H, J = 7.6 Hz, HAr), 7.59 (d, 1H,
J = 7.6 Hz, HAr), 8.08 (dd, J = 1.94, 1.77 Hz, 1H, HAr),
12.44 (br s, 1H, SH); 13C NMR (100 MHz, CDCl3) d
(ppm) 10.93 (CH3CH2), 17.49 (CH3–C6), 32.29 (CH2CH3),
53.49 (OCH3), 57.62 (CHNH ), 121.73 (Ar), 127.52 (Ar),
128.21 (Ar), 131.89 (Ar), 151.09 (C6), 165.87 (C5), 170.19
(C3); MS (EI) m/z (rel. intensity) 306 (M+, 14%), 278
(19), 262 (11), 234 (5), 157 (13), 146 (76), 150 (26), 131
(28), 118 (17), 105 (13), 91 (37) and 91 (11). Anal. Calcd
for C14H18N4O2S: C, 54.88; H, 5.92; N, 18.29; S, 10.47.
Found: C, 54.79; H, 5.97; N, 18.36; S, 10.38.
4.1.4.
4-[1-(20-Methylphenyl)propyl]amino-3-mercapto-6-
methyl-4H-1,2,4-triazin-5-one 4b. White solid, mp 152–
25
153 ꢁC; ½aꢁD ¼ ꢀ96:8 (c 0.98, CHCl3); HPLC conditions:
4.1.7. 4-[1-(40-Methoxyphenyl)propyl]amino-3-mercapto-6-
i
12% PrOH in hexane, retention times, 14.62 min (minor,
methyl-4H-1,2,4-triazin-5-one 4e. White solid, 144–
25
R-isomer) and 22.97 min (major, S-isomer); IR (cmꢀ1
)
145 ꢁC; ½aꢁD ¼ ꢀ34:6 (c 2.39, CH2Cl2); HPLC conditions:
3270 (NH), 1701 (C@O), 1207 (C@S); 1H NMR
(400 MHz, CDCl3): d (ppm) 0.79 (t, 3H, J = 7.4 Hz,
CH3CH2), 1.78–1.90 (m, 1H, CH2CH3), 1.96–2.09 (m,
1H, CH2CH3), 2.32 (s, 3H, Ar–CH3), 2.56 (s, 3H, CH3–
C6), 3.28 (br s, 1H, NHC), 3.99–4.08 (m, 1H, CHNH),
6.78–6.98 (m, 2H, HAr), 7.09–7.44 (m, 2H, HAr), 12.29
(br s, 1H, SH); 13C NMR (100 MHz, CDCl3): d (ppm)
10.66 (CH3CH2), 16.69 (CH3–C6), 21.49 (Ar–CH3), 31.93
(CH2CH3), 57.36 (CHNH), 120.93 (Ar), 126.71 (Ar),
127.85 (Ar), 133.29 (Ar), 152.31 (C6), 165.92 (C5), 169.67
(C3); MS (EI) m/z (rel. intensity) 290 (M+, 9%), 262 (33),
246 (6.5), 218 (8), 158 (11), 146 (56), 134 (14), 131 (38),
119 (13), 109 (29), 105 (14) and 91 (6). Anal. Calcd for
C14H18N4OS: C, 57.91; H, 6.25; N, 19.29; S, 11.04. Found:
C, 60.02; H, 6.24; N, 19.31; S, 11.09.
15% PrOH in hexane, retention times, 9.32 min (minor,
i
R-isomer) and 15.52 min (major, S-isomer); IR (cmꢀ1
)
3285 (NH), 1695 (C@O), 1210 (C@S); 1H NMR
(400 MHz, CDCl3): d (ppm) 0.87 (t, 3H, J = 7.5 Hz,
CH3CH2), 1.75–1.92 (m, 1H, CH2CH3), 1.98–2.11 (m,
1H, CH2CH3), 2.42 (s, 3H, CH3–C6), 3.34 (br s, 1H,
NHC), 3.82 (s, 3H, OCH3), 4.09–4.17 (m, 1H, CHNH),
6.93 (d, J = 8.7 Hz, 2H, HAr), 7.26 (d, J = 8.7 Hz, 2H,
HAr), 11.87 (br s, 1H, SH); 13C NMR (100 MHz, CDCl3):
d (ppm) 11.7 (CH3CH2), 17.87 (CH3–C6), 31.3 (CH2CH3),
55.59 (OCH3), 56.44 (CHNH), 115.87 (Ar), 126.67 (Ar),
134.72 (Ar), 146.43 (Ar), 152.52 (C6), 164.55 (C5), 171.09
(C3); MS (EI) m/z (rel. intensity) 306 (M+, 18%), 279
(22), 262 (6), 234 (4), 157 (24), 150 (21), 146 (64), 130
(16), 119 (9) and 105 (7). Anal. Calcd for C14H18N4O2S: